NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 100 filers reported holding NUVATION BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $395,336 | +641.6% | 135,389 | +824.4% | 0.00% | – |
| Q1 2024 | $53,311 | +47.2% | 14,646 | -38.9% | 0.00% | – |
| Q4 2023 | $36,207 | -80.5% | 23,978 | -82.7% | 0.00% | – |
| Q3 2023 | $185,713 | -32.9% | 138,592 | -9.9% | 0.00% | – |
| Q2 2023 | $276,898 | +12.5% | 153,832 | +3.7% | 0.00% | – |
| Q1 2023 | $246,198 | -14.6% | 148,312 | -1.2% | 0.00% | – |
| Q4 2022 | $288,348 | -13.4% | 150,181 | +1.0% | 0.00% | -100.0% |
| Q3 2022 | $333,000 | -32.3% | 148,697 | -2.0% | 0.00% | 0.0% |
| Q2 2022 | $492,000 | -42.0% | 151,741 | -6.0% | 0.00% | 0.0% |
| Q1 2022 | $849,000 | -44.1% | 161,445 | -9.7% | 0.00% | -50.0% |
| Q4 2021 | $1,519,000 | +14.1% | 178,734 | +33.4% | 0.00% | 0.0% |
| Q3 2021 | $1,331,000 | +192.5% | 133,948 | +173.9% | 0.00% | +100.0% |
| Q2 2021 | $455,000 | – | 48,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,247,340 | $49,401,000 | 15.77% |
| Aisling Capital Management LP | 2,541,009 | $8,233,000 | 5.87% |
| EDBI Pte Ltd | 1,270,504 | $4,116,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $3,684,000 | 3.36% |
| Deep Track Capital, LP | 11,471,281 | $37,167,000 | 2.44% |
| EcoR1 Capital, LLC | 13,896,543 | $45,025,000 | 1.55% |
| Boxer Capital, LLC | 4,341,009 | $14,065,000 | 0.89% |
| Baupost Group | 10,418,194 | $33,755,000 | 0.50% |
| Redmile Group, LLC | 3,471,709 | $11,248,000 | 0.43% |
| 683 Capital Management, LLC | 1,766,657 | $5,724,000 | 0.40% |